Resources Click to access Industry Related Topics Read More Resources Click to access Industry Related Topics Read More Strategic Pillars Click to access Industry Related Topics Read More Resources Click to access Industry Related Topics Read More Read More Click to access Industry Related Topics Patients Read More Click to access Industry Related Topics Events Read More Click to access Industry Related Topics Resources

About Us

PIA-PR gathers and represents research-based multinational pharmaceutical and biotechnology companies with operations on the island. There are 11 corporations with 12 manufacturing sites and 11 commercial entities.

Mid adult businessman gestures as he discusses sales with a group of colleagues during a meeting.

Mission

Foster an environment that strengthens Puerto Rico’s bio-pharmaceutical industry’s global competitiveness and improves healthcare outcomes for its citizens.

Strategy

  • Improve competitiveness to retain and attract operations to Puerto Rico.
  • Improve Patient Outcomes / Healthcare Sustainability Initiative
  • Drive Social Capital
  • Build strong networks with key stakeholders
  • Strengthen PIA’s position and capabilities
Low angle view of hands of multiracial group of people working with ideas and brainstorming together to make decisions with documents on table in creative office teamwork

Board Members

PIA’s Board of Directors is composed of 10 members represented by the company’s top executive in Puerto Rico. Five members represent the manufacturing sector and five the commercial sector. In addition, there are three ex-officio members: The Operations Director, the legal Counsel, and the Advisor to the Board.

Juan I. Diddi Chairperson
General Manager Puerto Rico & Caribe
Bristol Myers Squibb
David L. Thompson Vice Chairperson Site Head
AbbVie
Brandon P. Paschal Treasurer SVP Global Dry Products Operations,
President & GM , Lilly del Caribe
Glorimar Torres Secretary General Manager
Amgen Commercial Operations

Board Members

PIA’s Board of Directors is composed of 10 members represented by the company’s top executive in Puerto Rico. Five members represent the manufacturing sector and five the commercial sector. In addition, there are three ex-officio members: The Operations Director, the legal Counsel, and the Advisor to the Board.

Juan I. Diddi Chairperson
General Manager
Puerto Rico & Caribe
Bristol Myers Squibb
David L. Thompson Vice Chairperson Site Head
AbbVie
Brandon P. Paschal Treasurer SVP Global Dry Products Operations,
President & GM , Lilly del Caribe
Glorimar Torres Secretary General Manager
Amgen Commercial Operations

Membership

Members

The Pharmaceutical Industry Association members feel proud of their role as a very important part of the Puerto Rican community and of the many initiatives undertaken, individually and collectively, to improve the quality of life in our country.

Our members are pharmaceutical and biotechnology companies organized in manufacturing operations and commercial entities in Puerto Rico, each represented by its respective General Manager.

Associate Members

In 1997, PIA-PR incorporated the Associate Membership concept and invited a select group of pharmaceutical industry suppliers, vendors, consultants and professionals participate to forge a mutually beneficial long-term alliance.

Chosen because of their tradition of support to the pharmaceutical industry, these organizations are representative of PIA-PR’s business partners and have enriched the Association’s member companies with their quality products and services. Following are excerpts from their Associate Member organization’s many products and services.

Philanthropy

We care about the communities where you live:

Volunteering

Volunteering

Donations

Donations

Sustainability

Sustainability

Scholarships

Scholarships

1st Job Experiences

1st Job Experiences

Training & Education

Training & Education

Social Impact

“Conectados por los Pacientes” an effort by the Patient-Centered Committee of the Puerto Rico Pharmaceutical Industry Association (PIA), seeks to strengthen collaboration with leaders of patient organizations, foster capacity building, and provide educational workshops through expert resources and the sharing of experiences.

GNP 30%* Jobs 14,500 (Direct) | 50,000 (Indirect) Investment Assets Base ~ $10,700 MM Maint. Cap. $450 MM+ 2 of top 10 global medicines Payroll $1,150 MM $80,000/yr Salary Taxes Corporate ~$1,500 MM | Personal ~$140 MM Clinical Trials >200 across different municipalities Key Partnerships and Patient Support Programs >100 with focus on healthcare delivery, early diagnosis, prevention and financial assistance Exports 70% | >120 countries Driving Impact for Patients, Communities, and Economy